LUCAS KIRCHHOFF: Open Payments
NPI 1255086682 · OVERLAND PARK, KS. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$479 in 24 payments from 11 companies in 2025. Trend: 2023 $1,395 · 2024 $729 · 2025 $479
Food & beverage: $479
| Company | Payments | Amount |
|---|---|---|
| Alkermes, Inc. | 5 | $106 |
| Lundbeck LLC | 4 | $74 |
| Otsuka America Pharmaceutical, Inc. | 3 | $63 |
| Vanda Pharmaceuticals Inc. | 2 | $53 |
| E.R. Squibb & Sons, L.L.C. | 2 | $40 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $35 |
| Janssen Pharmaceuticals, Inc | 1 | $28 |
| Axsome Therapeutics, Inc. | 2 | $28 |
| ABBVIE INC. | 1 | $20 |
| Noven Therapeutics, LLC | 1 | $18 |
Products named: ARISTADA, REXULTI, ABILIFY MAINTENA, HETLIOZ, CAPLYTA, SPRAVATO, Auvelity, COBENFY.
Industry payments across KS — which companies pay providers there.
